Theriva Biologics Reports $18.3M In Cash For Q1 2024, Which Is Expected To Provide Runway Into The First Quarter Of 2025
Theriva Biologics报告称,2024年第一季度有1830万美元的现金,预计将为2025年第一季度提供资金
Theriva Biologics Reports $18.3M In Cash For Q1 2024, Which Is Expected To Provide Runway Into The First Quarter Of 2025
Theriva Biologics报告称,2024年第一季度有1830万美元的现金,预计将为2025年第一季度提供资金
使用浏览器的分享功能,分享给你的好友吧